94 related articles for article (PubMed ID: 7683485)
1. The management of recurrent acute myelogenous leukaemia at a single centre over a fifteen-year period.
Davis CL; Rohatiner AZ; Lim J; Whelan JS; Oza AM; Amess J; Love S; Stead E; Lister TA
Br J Haematol; 1993 Mar; 83(3):404-11. PubMed ID: 7683485
[TBL] [Abstract][Full Text] [Related]
2. In vivo purging with high-dose cytarabine followed by high-dose chemoradiotherapy and reinfusion of unpurged bone marrow for adult acute myelogenous leukemia in first complete remission.
Stein AS; O'Donnell MR; Chai A; Schmidt GM; Nademanee A; Parker PM; Smith EP; Snyder DS; Molina A; Stepan DE; Spielberger R; Somlo G; Margolin KA; Vora N; Lipsett J; Lee J; Niland J; Forman SJ
J Clin Oncol; 1996 Aug; 14(8):2206-16. PubMed ID: 8708709
[TBL] [Abstract][Full Text] [Related]
3. Autologous bone marrow transplantation for haematological malignancies--experiences of the centre of Zagreb.
Nemet D; Labar B; Bogdanic V; Skodlar J; Petrovecki M; Mrsic M; Maravic N; Sneller V; Radman I; Kovacevic-Metelko J
Wien Med Wochenschr; 1995; 145(2-3):61-4. PubMed ID: 7762256
[TBL] [Abstract][Full Text] [Related]
4. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups.
Zittoun RA; Mandelli F; Willemze R; de Witte T; Labar B; Resegotti L; Leoni F; Damasio E; Visani G; Papa G
N Engl J Med; 1995 Jan; 332(4):217-23. PubMed ID: 7808487
[TBL] [Abstract][Full Text] [Related]
5. Mitoxantrone and cytosine arabinoside as treatment for acute myelogenous leukemia (AML) at first recurrence.
MacCallum PK; Davis CL; Rohatiner AZ; Lim J; Gupta RK; Whelan JS; Price CG; Evans ML; Amess JA; Leahy M
Leukemia; 1993 Oct; 7(10):1496-9. PubMed ID: 8412309
[TBL] [Abstract][Full Text] [Related]
6. Short term therapy (STT) for acute myelogenous leukaemia (AML).
Rohatiner AZ; Battista R; Bassan R; Love S; Oza AM; Whelan JS; Lim J; Buelli M; Viero P; D'Emillio A
Leukemia; 1992; 6 Suppl 2():85-8. PubMed ID: 1578952
[TBL] [Abstract][Full Text] [Related]
7. Outcome assessment of age group-specific (+/- 50 years) post-remission consolidation with high-dose cytarabine or bone marrow autograft for adult acute myelogenous leukemia.
Bassan R; Raimondi R; Lerede T; D'emilio A; Buelli M; Borleri G; Personeni A; Bellavita P; Rodeghiero F; Barbui T
Haematologica; 1998 Jul; 83(7):627-35. PubMed ID: 9718868
[TBL] [Abstract][Full Text] [Related]
8. Comparison of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission: a prospective controlled trial.
Reiffers J; Gaspard MH; Maraninchi D; Michallet M; Marit G; Stoppa AM; Corront B; David B; Gastaut JA; Scotto JJ
Br J Haematol; 1989 May; 72(1):57-63. PubMed ID: 2660902
[TBL] [Abstract][Full Text] [Related]
9. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
[TBL] [Abstract][Full Text] [Related]
10. Outcome of patients with acute myelogenous leukemia after second salvage therapy.
Giles F; O'Brien S; Cortes J; Verstovsek S; Bueso-Ramos C; Shan J; Pierce S; Garcia-Manero G; Keating M; Kantarjian H
Cancer; 2005 Aug; 104(3):547-54. PubMed ID: 15973664
[TBL] [Abstract][Full Text] [Related]
11. Nucleolar organizer region counts predict complete remission, remission duration, and survival in adult acute myelogenous leukemia patients.
Pich A; Chiusa L; Audisio E; Marmont F
J Clin Oncol; 1998 Apr; 16(4):1512-8. PubMed ID: 9552060
[TBL] [Abstract][Full Text] [Related]
12. Busulfan plus etoposide as a preparative regimen for autologous bone marrow transplantation for acute myelogenous leukemia: an update.
Linker CA; Damon LE; Ries CA; Rugo HS; Wolf JL
Semin Oncol; 1993 Aug; 20(4 Suppl 4):40-8; quiz 49. PubMed ID: 8342075
[TBL] [Abstract][Full Text] [Related]
13. Intensive short term therapy with granulocyte-macrophage-colony stimulating factor support, similar to therapy for acute myeloblastic leukemia, does not improve overall results for adults with acute lymphoblastic leukemia. GOELAMS Group.
Ifrah N; Witz F; Jouet JP; François S; Lamy T; Linassier C; Pignon B; Berthou C; Guyotat D; Cahn JY; Harousseau JL
Cancer; 1999 Oct; 86(8):1496-505. PubMed ID: 10526278
[TBL] [Abstract][Full Text] [Related]
14. Intensive chemotherapy for poor prognosis myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML) following MDS of more than 6 months duration. A pilot study by the Leukemia Cooperative Group of the European Organisation for Research and Treatment in Cancer (EORTC-LCG).
de Witte T; Suciu S; Peetermans M; Fenaux P; Strijckmans P; Hayat M; Jaksic B; Selleslag D; Zittoun R; Dardenne M
Leukemia; 1995 Nov; 9(11):1805-11. PubMed ID: 7475266
[TBL] [Abstract][Full Text] [Related]
15. Improved survival for patients with acute myelogenous leukemia.
Mitus AJ; Miller KB; Schenkein DP; Ryan HF; Parsons SK; Wheeler C; Antin JH
J Clin Oncol; 1995 Mar; 13(3):560-9. PubMed ID: 7884416
[TBL] [Abstract][Full Text] [Related]
16. Autologous bone marrow transplant in acute myeloid leukemia in first remission.
Cassileth PA; Andersen J; Lazarus HM; Colvin OM; Bennett JM; Stadtmauer EA; Kaizer H; Weiner RS; Edelstein M; Oken MM
J Clin Oncol; 1993 Feb; 11(2):314-9. PubMed ID: 8426209
[TBL] [Abstract][Full Text] [Related]
17. [Intensive post-remission therapy in acute myeloid leukemia. Results of a prospective comparative study by the South Germany Hemoblastosis Group].
Hübner G; Link H; Schönrock-Nabulsi P; Wandt H; Gramatzki M; Löffler B; Fackler-Schwalbe I; Queisser W; Brack N; Geer T; Raab M; Ohl S; Schneider B; Schneider C; Freund M; Poliwoda H; Ehninger G
Med Klin (Munich); 1996 Apr; 91 Suppl 3():26-32. PubMed ID: 8692115
[TBL] [Abstract][Full Text] [Related]
18. Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia. The Associazione Italiana Ematologia ed Oncologia Pediatrica Cooperative Group.
Amadori S; Testi AM; Aricò M; Comelli A; Giuliano M; Madon E; Masera G; Rondelli R; Zanesco L; Mandelli F
J Clin Oncol; 1993 Jun; 11(6):1046-54. PubMed ID: 8501490
[TBL] [Abstract][Full Text] [Related]
19. [Prognosis of children with acute myelocytic leukemia after first relapse].
Creutzig U; Ritter J; Boos J; Zimmermann M; Bender-Götze C; Stahnke K
Klin Padiatr; 1998; 210(4):207-11. PubMed ID: 9743954
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic bone marrow transplantation versus intensification chemotherapy for acute myelogenous leukaemia in first remission: a prospective controlled trial.
Conde E; Iriondo A; Rayon C; Richard C; Fanjul E; Garijo J; Hermosa V; Coma A; Bello C; Carrera D
Br J Haematol; 1988 Feb; 68(2):219-26. PubMed ID: 3280005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
